MedPath

GEN-TEMAZEPAM 30MG

GEN-TEMAZEPAM 30MG

Discontinued
DIN Number

02231616

Drug Class

Human

Market Date

Jul 8, 1997

Company
HC

genpharm ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02231616
AIG Number0114415001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD07 TEMAZEPAM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

TEMAZEPAMActive
Strength: 30 MG
Monograph: TEMAZEPAM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.